Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca and FibroGen collaborate to develop and commercialise FG-4592, a treatment for anaemia in chronic kidney disease and end-stage renal disease
-
AstraZeneca and Bristol-Myers Squibb resubmit dapagliflozin New Drug Application for the treatment of type 2 diabetes in the U.S
-
US FDA acknowledges receipt of resubmission of the New Drug Application for investigational compound dapagliflozin for the treatment of type 2 diabetes
-
Simon Lowth, Chief Financial Officer, to leave AstraZeneca
-
AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
-
AstraZeneca Completes Acquisition Of Pearl Therapeutics
-
AstraZeneca and Bristol-Myers Squibb announce top-line results for SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® (SAXAGLIPTIN)
-
AstraZeneca selects location for new global R&D centre and corporate headquarters in Cambridge, UK
-
MedImmune, AstraZeneca’s biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
-
AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
